Abstract: Vitronectin receptor antagonists, their preparation and their use The present invention relates to compounds of the formula I,
A—B—D—E—F—G (I)
in which A, B, D, E, F and G have the meanings given in the patent claims, to their preparation and to their use as medicaments. The compounds of the invention are used as vitronectin receptor antagonists and as inhibitors of bone resorption.
Type:
Grant
Filed:
February 8, 2001
Date of Patent:
November 19, 2002
Assignees:
Hoechst Aktiengellschaft, Genentech, Inc.
Inventors:
Volkmar Wehner, Hans Ulrich Stilz, Anuschirwan Peyman, Karlheinz Scheunemann, Jean-Marie Ruxer, Denis Carniato, Jean-Michel Lefrancois, Thomas Richard Gadek, Robert McDowell
Abstract: The invention relates to cyclic diphosphoric esters of the formula ##STR1## with R=methylethylene, 1,3-cyclohexylene, 1,4-cyclo-hexylene or 1,3-phenylene, a process for their preparation and their use as flame retardants.
Abstract: The invention relates to a process for the preparation of mixtures of synthetic, crystalline kenyaite and salts which split off oxygen. For this purpose, 1 mol of soda-water glass which has a molar ratio of SiO.sub.2 :Na.sub.2 O=1:(0.25 to 0.5) is mixed with 0.1 to 0.9 mol of a compound which has a pH of less than 10.5 in molar aqueous concentration, as a neutralizing agent. In the presence of kenyaite seed crystals, the reaction mixture is heated at temperatures from 373 to 523 K. in an autoclave for 1 to 10 hours and, after cooling, 0.15 to 1.5 mol of hydrogen peroxide are added per mol of soda-water glass employed. The solid is isolated from the reaction suspension as dry substance.
Abstract: A very active catalyst system for olefin polymerization comprises a cocatalyst, preferably an aluminoxane, and a metallocene of the formula I ##STR1## in which, preferably, M.sup.1 is Zr or Hf, R.sup.1 and R.sup.2 are alkyl or halogen, R.sup.3 is hydrogen, R.sup.4 to R.sup.6 are alkyl or aryl, --(CR.sup.8 R.sup.9).sub.m --R.sup.7 --(CR.sup.8 R.sup.9).sub.n is a single- or multi-membered chain, in which R.sup.7 can also be a (substituted) hetero atom, and m+n is zero or 1.
Type:
Grant
Filed:
November 24, 1992
Date of Patent:
July 12, 1994
Assignee:
Hoechst Aktiengellschaft
Inventors:
Andreas Winter, Jurgen Rohrmann, Volker Dolle, Frank Kuber
Abstract: A description is given of a process for the preparation of a compound of the formula I ##STR1## in which R.sup.1, R.sup.2 and R.sup.3 (identical or different) represent H, alkyl having 1-2 carbon atoms and F, Cl, Br or I;R.sup.4 represents H, alkyl having 1-4 carbon atoms, n represents the numbers 2-5, andR.sup.5 represents a radical which can be eliminated under physiological conditions or represents hydrogen, and its physiologically tolerated salts.They are effective remedies for diarrhea.
Type:
Grant
Filed:
May 4, 1989
Date of Patent:
July 17, 1990
Assignee:
Hoechst Aktiengellschaft
Inventors:
Heinrich C. Englert, Max Hropot, Hans-Jochen Lang, Rainer Greger
Abstract: The reaction for the preparation of 1-oxa-3,8-diaza-4-oxo-spiro[4.5]decane compounds of the formula ##STR1## proceeds more rapidly and more completely if it is performed in the presence of a phase transfer catalyst in an aromatic hydrocarbon which is liquid at room temperature.